GRANULES INDIA
Back to Cashflow Statement
|
GRANULES INDIA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹7.66 Cr | ₹-440 Cr | ₹190 Cr | ₹-299 Cr | ₹-213 Cr |
What is the latest Cash Flow from Financing Activities ratio of GRANULES INDIA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹7.66 Cr |
Mar2023 | ₹-440 Cr |
Mar2022 | ₹190 Cr |
Mar2021 | ₹-299 Cr |
Mar2020 | ₹-213 Cr |
How is Cash Flow from Financing Activities of GRANULES INDIA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹7.66 Cr | Positive | |
Mar2023 | ₹-440 Cr | Negative | |
Mar2022 | ₹190 Cr | Positive | |
Mar2021 | ₹-299 Cr | Negative | |
Mar2020 | ₹-213 Cr | - |
Compare Cash Flow from Financing Activities of peers of GRANULES INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GRANULES INDIA | ₹12,510.6 Cr | -2.5% | -12.6% | 15.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,395.0 Cr | -4.1% | -9.8% | 8.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,422.0 Cr | -2.9% | -0.3% | 63.8% | Stock Analytics | |
CIPLA | ₹119,252.0 Cr | 0.1% | 4.4% | 2.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹101,889.0 Cr | -1.3% | -6.5% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,191.9 Cr | -4% | -5.9% | -7.8% | Stock Analytics |
GRANULES INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GRANULES INDIA | -2.5% |
-12.6% |
15.3% |
SENSEX | -2% |
-2.3% |
2.5% |
You may also like the below Video Courses